Champions Oncology
CSBR
CSBR
25 hedge funds and large institutions have $49M invested in Champions Oncology in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
14% more funds holding
Funds holding: 22 → 25 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.18% less ownership
Funds ownership: 42.56% → 41.38% (-1.2%)
Holders
25
Holding in Top 10
1
Calls
$192K
Puts
$9K
Top Buyers
| 1 | +$162K | |
| 2 | +$129K | |
| 3 | +$111K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$98.8K |
| 5 |
VF
Virtu Financial
New York
|
+$95K |
Top Sellers
| 1 | -$825K | |
| 2 | -$236K | |
| 3 | -$7.83K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$6.23K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$309 |